Femasys Inc. Share Price

Femasys Inc. Share Price

NASDAQ: FEMY | Micro Cap
$1.39
+0.00 (0.00%) Last updated on 29 Oct, 2026 | 20:10 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Femasys Inc. Stock Performance

Open
$1.41
Prev. Close
$1.39
Circuit Range
N/A
Day Range
$1.39 - $1.42
Year Range
$0.29 - $6.14
Volume
846
Average Traded
$1.41

Femasys Inc. Share Price Today

As of 29 October 2026, Femasys Inc.'s share price is $1.39. The stock opened at $1.41, compared to its previous close of $1.39. During today's trading session, Femasys Inc.'s share price traded between $1.39 and $1.42, with an average price of $1.40. Over the past 52 weeks, the stock has recorded a high of $6.14 and a low of $0.29. In terms of performance, Femasys Inc.'s share price has risen by 277.72% over the last six months and is up 118.90% on a year-on-year basis.

Femasys Inc. Share Price Chart

Line chart of the Femasys Inc. price trend over the selected period. The price rose overall, ranging from 1.39 to 1.44, ending at 1.39.
$1.39$1.42
L
Show Current Price
H

Femasys Inc. Stock Fundamentals & Key Indicators

Market Cap
$54.97M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.47
Revenue (TTM)
$2.29B
Return On Equity (TTM)
-304.78%
Profit Margin
-813.54%
Debt to Equity
0.89
Quarterly Earnings Growth YoY
-6.68%

Femasys Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.73$0.81$0.42$0.33
Net Profit-$4.19-$3.95$0.33-$4.47
Net Profit Margin-573.97%-487.65%78.57%-1354.55%
Income ChangeN/A5.73%108.35%-1454.55%

Femasys Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.21$1.07$1.63$2.29
Net Profit-$11.39-$14.25-$18.82-$18.63
Net Profit Margin-941.32%-1331.78%-1154.60%-813.54%
Income ChangeN/A-25.11%-32.07%1.01%

About Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Femasys Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$2.18
$1.39
-35.65%
Sep 2026
$3.35
$2.16
-23.27%
Aug 2026
$2.95
$2.81
-4.09%
Jul 2026
$4.28
$2.94
-21.73%
Jun 2026
$0.37
$3.75
+900.00%
May 2026
$0.37
$0.38
+1.90%
Apr 2026
$0.44
$0.37
-12.80%
Mar 2026
$0.55
$0.42
-25.83%
Feb 2026
$0.53
$0.57
+5.18%
Jan 2026
$0.62
$0.54
-5.75%
Dec 2025
$0.95
$0.57
-44.00%
Nov 2025
$0.76
$1.02
+61.42%

FEMY Share Price FAQs